At Acerus, we are dedicated to offering innovative solutions in Men’s Health.

The Acerus product portfolio is built with growing diversity and a growing global footprint. Our strategic focus is in the fields of Urology, Andrology and Endocrinology to bring valuable solutions to market that positively impact the health of patients. These innovative products are developed internally or acquired externally and then we commercialize products globally through our own resources or through partners.

Our products in market currently include:

NATESTO®, a product utilizing our licensed nasal gel technology, is the first and only testosterone nasal gel available in Canada and in the United States for replacement therapy in adult males diagnosed with hypogonadism.

View More

ESTRACE® is an oral, plant-derived 17-beta estradiol therapy indicated for symptomatic relief of menopausal symptoms in Canada.

View More